臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shih j y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 951-975 / 1137 (共46頁)
<< < 34 35 36 37 38 39 40 41 42 43 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-03-06T05:26:16Z	Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ?2 cm in maximal dimension	YIH-LEONG CHANG; Yang P.-C.; Lin M.-W.; Wu C.-T.; Shih J.-Y.
臺大學術典藏	2020-03-06T05:26:13Z	DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers	Lin Y.-C.; Lin Y.-C.; Shih J.-Y.; Huang W.-J.; Chao S.-W.; YIH-LEONG CHANG; Chen C.-C.
臺大學術典藏	2020-03-06T05:26:09Z	The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients	Wu S-G.; Liu Y.-N.; Tsai M.-F.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.
臺大學術典藏	2020-03-06T05:26:07Z	The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition	Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2020-03-06T05:26:05Z	Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C	Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; YIH-LEONG CHANG; Yu S.-L.; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2020-03-06T05:26:05Z	Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors	Wu S.-G.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2020-03-06T05:26:04Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏	2020-03-06T05:26:04Z	Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression	Chen C.-Y.; Chen Y.-Y.; Chen J.J.W.; Chen K.-Y.; Ho C.-C.; Shih J.-Y.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.
臺大學術典藏	2020-03-06T05:26:03Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; YIH-LEONG CHANG; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.
臺大學術典藏	2020-03-06T05:26:02Z	IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer	Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; YIH-LEONG CHANG; Yu C.-J.; Shih J.-Y.
臺大學術典藏	2020-03-06T05:26:01Z	Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer	Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; Tsai T.-H.; Gow C.-H.; YIH-LEONG CHANG; Shih J.-Y.
臺大學術典藏	2020-03-06T05:26:00Z	Primary resistance to osimertinib despite acquired T790M	Chang L.-K.; YIH-LEONG CHANG; Shih J.-Y.
臺大學術典藏	2020-03-06T05:26:00Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2020-03-06T03:43:07Z	Using GHSOM to construct legal maps for Taiwan's securities and futures markets	Shih J.-Y.; Chang Y.-J.; Chen W.-H.; WUN-HWA CHEN
臺大學術典藏	2020-03-06T03:43:04Z	Creating virtual collaborative team through the construction of expertise spaces	Chen W.-H.;Shih J.-Y.;Hsieh M.-J.; Chen W.-H.; Shih J.-Y.; Hsieh M.-J.; WUN-HWA CHEN
臺大學術典藏	2020-03-06T03:43:04Z	Developing target marketing models for personal loans	Shih J.-Y.;Chen W.-H.;Chang Y.-J.; Shih J.-Y.; Chen W.-H.; Chang Y.-J.; WUN-HWA CHEN
臺大學術典藏	2020-03-06T03:43:03Z	A study of Taiwan's issuer credit rating systems using support vector machines	Chen W.-H.;Shih J.-Y.; Chen W.-H.; Shih J.-Y.; WUN-HWA CHEN
臺大學術典藏	2020-03-05T08:04:11Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	Chen Y.-F.; MIN-SHU HSIEH; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.
臺大學術典藏	2020-03-05T08:04:09Z	Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion	Tsai T.-H.; Wu S.-G.; MIN-SHU HSIEH; Yu C.-J.; Yang J.C.H.; Shih J.-Y.
臺大學術典藏	2020-03-05T08:04:08Z	Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations	Chen Y.-F.; MIN-SHU HSIEH; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2020-03-05T08:04:03Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.;Min-Shu Hsieh;Lee M.-R.;Keng L.-T.;Ko J.-C.;Shih J.-Y.; Liang S.-K.; MIN-SHU HSIEH; Lee M.-R.; Keng L.-T.; Ko J.-C.; Shih J.-Y.
臺大學術典藏	2020-03-05T08:04:03Z	Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer	Chen C.-Y.;Chen Y.-Y.;Min-Shu Hsieh;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Yu C.-J.; Chen C.-Y.; Chen Y.-Y.; MIN-SHU HSIEH; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.
臺大學術典藏	2020-03-05T08:04:02Z	Coexistence of the BRAF Mutation and EGFR Exon 20 Insertion in a Patient with Lung Adenocarcinoma	Chang L.-C.;Chen K.-Y.;Shih J.-Y.;Yu C.-J.;Min-Shu Hsieh; Chang L.-C.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.; MIN-SHU HSIEH
臺大學術典藏	2020-03-05T08:04:02Z	A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population	Gow C.-H.;Min-Shu Hsieh;Wu S.-G.;Shih J.-Y.; Gow C.-H.; MIN-SHU HSIEH; Wu S.-G.; Shih J.-Y.
臺大學術典藏	2020-03-05T08:04:01Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; MIN-SHU HSIEH; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Min-Shu Hsieh;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.

顯示項目 951-975 / 1137 (共46頁)
<< < 34 35 36 37 38 39 40 41 42 43 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2822924
	造訪人次 : 30095672 線上人數 : 876 教育部委託研究計畫計畫執行:國立臺灣大學圖書館